{
    "Trade/Device Name(s)": [
        "G4TM Meter",
        "G4TM Test Strips",
        "G4TM Control Solutions"
    ],
    "Submitter Information": "US Diagnostics, Inc.",
    "510(k) Number": "K051651",
    "Predicate Device Reference 510(k) Number(s)": [
        "K024194",
        "K984261",
        "K021513"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "March 10, 2006",
    "Summary Letter Received Date": "March 10, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "G4TM Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection",
        "Enzyme reaction (dehydrogenase glucose)"
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for G4TM Blood Glucose Monitoring System for quantitative glucose measurement using electrochemical detection in capillary whole blood",
    "Indications for Use Summary": "Quantitative measurement of glucose level in capillary whole blood as an aid in monitoring the effectiveness of diabetes management in home and clinical settings, including alternate site testing on the arm.",
    "fda_folder": "Clinical Chemistry"
}